VORAPAXAR for Peripheral vascular disorder: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where VORAPAXAR was used for Peripheral vascular disorder.
Most Reported Side Effects for VORAPAXAR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Gastrointestinal haemorrhage | 15 | 7.9% | 1 | 7 |
| Epistaxis | 11 | 5.8% | 0 | 1 |
| Chest pain | 8 | 4.2% | 0 | 4 |
| Death | 8 | 4.2% | 8 | 0 |
| Drug dose omission | 8 | 4.2% | 0 | 1 |
| Haemorrhage | 7 | 3.7% | 0 | 2 |
| Dyspnoea | 6 | 3.2% | 0 | 4 |
| Haemoglobin decreased | 5 | 2.7% | 0 | 3 |
| Malaise | 5 | 2.7% | 1 | 1 |
| Rash | 5 | 2.7% | 0 | 1 |
Other Indications for VORAPAXAR
Product used for unknown indication (41)
Peripheral arterial occlusive disease (30)
Coronary artery disease (22)
Myocardial infarction (10)
Cardiovascular event prophylaxis (7)
Other Drugs Used for Peripheral vascular disorder
CLOPIDOGREL BISULFATE (212)
RIVAROXABAN (156)
ASPIRIN (145)
EVOLOCUMAB (126)
WARFARIN (48)
CILOSTAZOL (24)
APIXABAN (19)
PREGABALIN (18)
ATORVASTATIN (15)
ALIROCUMAB (12)